Afnan Jaufer, PhD, Author at American Association for Cancer Research (AACR)

December 11, 2025 by Afnan Jaufer, PhD

Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.

Learn More

October 28, 2025 by Afnan Jaufer, PhD

Since 1993, the American Association for Cancer Research (AACR) has invested more than $542 million in grants to sustain...

Learn More

September 18, 2025 by Afnan Jaufer, PhD

Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.

Learn More

Author: Afnan Jaufer, PhD